What are the contraindications for this drug?

It is contraindicated in patients with hypersensitivity to clindamycin or lincomycin.

What are the available specifications?

Available specifications include 2ML/0.3G and 600MG/4ML (5's/box).

Clindamycin Phosphate Injection 600mg - Advanced Antibiotic Treatment

Name: Clindamycin Phosphate Injection 600mg - Advanced Antibiotic Treatment
Brand: Anhui Medipharm Co., Ltd.
SKU: 1927890451

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$0.45-1.01

40,000 Box

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

AMC14040-02

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Oral Liquid

Type

Injection

Pharmaceutical Technology

Chemical Synthesis

OEM/ODM

Support

Standard

Bp, Cp

Delivery Time

30~60 Days

Function

Infections Caused by Susceptible Gram-Positive Org

Transport Package

5′ S/Box

Specification

600MG/4ML

Trademark

Medipharm/Shinepharm/OEM

Origin

China

HS Code

3004909099

Production Capacity

1000000 Boxes/Month

Key features

Broad-Spectrum Antibacterial: Effective against Gram-positive organisms, staphylococci, streptococci, pneumococci, and anaerobic pathogens.

OEM/ODM Support Available: Full customization options including designs and samples are supported for this product.

GMP Certified Production: Manufactured under GMP standards with BP and CP compliance for quality assurance.

Suitable for All Age Groups: Indicated for use in adults, elderly, and children over one month of age with specific dosing.

Flexible Delivery Time: Standard delivery time ranges from 30 to 60 days depending on order volume and season.

Multiple Payment Terms: Accepts T/T, LC, and D/P payment methods to accommodate international trade needs.

Established Export Experience: 14 years of export history with 80-100% repeat buyer rate and global market reach.

ISO Certified Management: Company holds ISO45001:2018 and ISO14001 certifications for safety and environmental management.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.94h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.